[1] JEMAL A,BRAY F,CENTER M M,et al.Global cancer statistics[J].CA Cancer J Clin,2011,61(2):69-90.
[2] FERLAY J,SHIN H R,BRAY F,et al.GLOBOCAN 2008,Cancer Incidence and Mortality Worldwide: IARC CancerBase No.10.Lyon,France:International Agency for Research on Cancer;Year.Available at:http://globocan.iarc.fr.2010.Last accessed 8/17/2010.
[3] LLOVET J M,DI-BISCEGLIE A M.Design and endpoints of clinical trials in hepatocellular carcinoma[J].J Natl Cancer Inst,2008,100:698-711.
[4] JANG J W,BAE S H,CHOI J Y,et al.A combination therapy with transarterial chemo-lipiodolization and systemic chemo-infusion for large extensive hepatocellular carcinoma invading portal vein in comparison with conservative management[J].Cancer Chemother Pharmacol,2007,59(1):9-15.
[5] LLOVET J M,BRUIX J.Systematic review of randomized trials for unresectable hepatocellular carcinoma:Chemoem-bolization improves survival[J].Hepatology,2003,37(2):429-442.
[6] TAKAYASU K,ARII S,IKAI I,et al.Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients[J].Gastroenterology,2006,131(2):461-469.
[7] KAMEL I R,LIAPI E,REYES D K,et al.Unresectable hepatocellular carcinoma:serial early vascular and cellular changes after transarterial chemoembolization as detected with MR imaging[J].Radiology,2009,250(2):466-473.
[8] LLOVET J M,REAL M I,MONTA?A X,et al.Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma:a randomised controlled trial[J].Lancet,2002,359(9319):1734-1739.
[9] PARK S Y,KIM J H,YOON H J,et al.Transarterial chemoembolization versus supportive therapy in the palliativetreatment of unresectable intrahepatic cholangio-carcinoma[J].Clin Radiol,2011,66(4):322-328.
[10] BUIJS M,VOSSEN J A,FRANGAKIS C,et al.Nonresectable hepatocellular carcinoma:long-term toxicity in patients treated with transarterial chemoembolization-single-center experience[J].Radiology,2008,249(1):346-354.
[11] 陈刚,邱少敏.经导管肝动脉化学栓塞术对原发性肝癌患者肝功能的影响[J].东南大学学报:医学版,2008,27(5):373-374.
[12] SEKI A,HORI S,KOBAYASHI K,et al.Transcatheter arterial chemoembolization with epirubicin-loaded superabsorbentpolymer microspheres for 135 hepatocellular carcinoma patients:single-centerexperience[J].Cardiovasc Intervent Radiol,2011,34(3):557-565.
[13] IZAKI K,SUGIMOTO K,SUGIMURA K,et al.Transcatheter arterial embolization for advanced tumor thrombus with marked arterioportal or arteriovenous shunt complicating hepatocellular carcinoma[J].Radiat Med,2004,22(3):155-162.
[14] CATURELLI E,SIENA D A,FUSILLI S,et al.Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with cirrhosis:evaluation of damage to nontumorous liver tissue-long-term prospective study[J].Radiology,2000,215(1):123-128.
[15] SACCO R,BERTINI M,PETRUZZI P,et al.Clinical impact of selective transarterial chemoembolization on hepatocellular carcinoma:a cohort study[J].World J Gastroenterol,2009,15(15):1843-1848.
[16] LO C M,NGAN H,TSO W K,et al.Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma[J].Hepatology,2002,35(5):1164-1171.
[17] UYGUN A,KADAYIFCI A,YESILOVA Z,et al.Serum leptin levels in patients with nonalcoholic steatohepatitis[J].Am J Gastroenterol,2000,95(12):3584-3589.
[18] CHAN A O,YUEN M F,HUI C K,et al.A prospective study regarding the complications of transcatheter intraarterial lipiodol chemoembolization in patients with hepatocellular carcinoma[J].Cancer,2002,94(6):1747-1752.
[19] CHUNG J W,PARK J H,HAN J K,et al.Hepatic tumors:predisposing factors for complications of transcatheter oily chemoembolization[J].Radiology,1996,198(1):33-40.
[20] JEON S H,PARK K S,KIM Y H,et al.Incidence and risk factors of acute hepatic failure after transcatheter arterialchemoembolization for hepatocellular carcinoma[J].Korean J Gastroenterol,2007,50(3):176-182.
[21] KUO Y H,LU S N,CHEN C L,et al.Hepatocellular carcinoma surveillance and appropriate treatment options improve survival for patients with liver cirrhosis[J].Eur J Cancer,2010,46(4):744-751.
[22] LUO J,GUO R P,LAI E C,et al.Transarterial chemoembolization for unresectable hepatocellular carcinoma withportal vein tumor thrombosis:a prospective comparative study[J].Ann Surg Oncol,2011,18(2):413-420.
[23] WOODALL C E,SCOGGINS C R,ELLIS S F,et al.Is selective internal radioembolization safe and effective for patients with inoperable hepatocellular carcinoma and venous thrombosis?[J].J Am Coll Surg,2009,208(3):375-382.
[24] LIAO C A,LEE C M,WU H C,et al.Lamivudine for the treatment of hepatitis B virus reactivation following chemotherapy for non-Hodgkin’s lymphoma[J].Br J Haematol,2002,116(1):166-169.
[25] PARK J W,PARK K W,CHO S H,et al.Risk of hepatitis B exacerbation is low after transcatheter arterial chemoembolization therapy for patients with HBV-related hepatocellular carcinoma:report of a prospective study[J].Am J Gastroenterol,2005,100(10):2194-2200.
[26] HUO T I,LEE S D,WU J C.Hepatitis after arterial embolization for hepatocellular carcinoma:Viral reactivation or ischemia?[J].Hepatology,2006,43(6):1400-1401.
[27] LAO X M,WANG D,SHI M,et al.Changes in hepatitis B virus DNA levels and liver function after transcatheterarterial chemoembolization of hepatocellular carcinoma[J].Hepatol Res,2011,41(6):553-563.
[28] 俞婷,俞谦,欧希龙,等.原发性肝癌肝动脉化疗栓塞后严重肝功能失代偿的相关因素分析[J].现代医学,2009,37(1):20-23.
[29] YAU T,YAO T J,CHAN P,et al.The outcomes of elderly patients with hepatocellular carcinoma treated withtransarterial chemoembolization[J].Cancer,2009,115(23):5507-5515.
[30] HUANG Y S,CHIANG J H,WU J C,et al.Risk of hepatic failure after transcatheter arterial chemoembolization for hepatocellular carcinoma:predictive value of the monoethylglycinexylidide test[J].Am J Gastroenterol,2002,97(5):1223-1227.
[31] MATSUI O,MIYAYAMA S,SANADA J,et al.Interventional oncology:new options for interstitial treatments and intravascular approaches:superselective TACE using iodized oil for HCC:rationale,technique and outcome[J].J Hepatobiliary Pancreat Sci,2010,17(4):407-409.
[32] GOLFIERI R,CAPPELLI A,CUCCHETTI A,et al.Efficacy of selective transarterial chemoembolization in inducing tumor necrosisin small (<5 cm) hepatocellular carcinomas[J].Hepatology,2011,53(5):1580-1589.
[33] HSU K F,CHU C H,CHAN D C,et al.Superselective transarterial chemoembolization vs hepatic resection forresectable early-stage hepatocellular carcinoma in patients with Child-Pugh class a liver function[J].Eur J Radiol,2012,81(3):466-471. |
